Simplex Trading
EIDX

Simplex Trading’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Simplex Trading’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed -$26K – 10596
2020
Q4 		$26K Buy
+2
New +$177 ﹤0.01% 6807
2020
Q1 		– Sell
-8
Closed -$45K – 8605
2019
Q4 		$45K Buy
+8
New +$396 ﹤0.01% 5305

Simplex Trading's EIDX Position: Q1 2020 in Review

Simplex Trading sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2020, closing a stake of 299 shares — an estimated $17K sold.

Simplex Trading first reported a position in EIDX in Q4 2019 and held it in 1 quarter. The position peaked at $17K in Q4 2019. 89 funds tracked by Wall St. Rank hold EIDX as of Q1 2020.

  • Simplex Trading reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Simplex Trading sold 299 Eidos Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $17K.
  • Simplex Trading first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Simplex Trading's Eidos Therapeutics, Inc. Common Stock position peaked at $17K in Q4 2019.
  • 89 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.